Wixela vs Combivent
What to choose Wixela or Combivent
Wixela is inhaler of type Control while Combivent is of Rescue type. Wixela and Combivent are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Combivent is manufactured by Boehringer Ingelheim. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substances of Combivent are Ipratropium and Albuterol. The available dosage for Combivent is 20/100.
The actual price for Wixela is roughly $240 per inhaler while current price for Combivent is around $397 per inhaler, said Judson Harris, a Research Assistant at the University of Kentucky and a Patient Representative at a clinic that uses Wixela and Combivent.
Wixela and Combivent Comparison
|Substance:||Fluticasone + Salmeterol||Ipratropium + Albuterol|